PSEUDOHYPERPHOSPHATAEMIA

This adverse event was reported 9 times

These drugs are most commonly taken by patients reporting PSEUDOHYPERPHOSPHATAEMIA:

# Drug Count
0 PANTOPRAZOLE 4
1 ALTEPLASE 2
2 ASPIRIN 2
3 ASPIRIN 325 MG 2
4 ASPIRIN 81 MG 2
5 METRONIDAZOLE 2
6 METRONIDAZOLE TOPICAL 2
7 SEVELAMER CARBONATE 2
8 SODIUM CHLORIDE 2
9 SODIUM CHLORIDE TABLET 2
See all common drugs associated with PSEUDOHYPERPHOSPHATAEMIA

PSEUDOHYPERPHOSPHATAEMIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SEVELAMER CARBONATE FOR ORAL SUSPENSION 1 0.2500
1 AMPICILLIN AND SULBACTAM 1 0.0011
2 AMPHOTERICIN B LIPOSOME 1 0.0004
3 AMPICILLIN SODIUM AND SULBACTAM SODIUM 1 0.0004
4 RIFABUTIN 1 0.0004
5 CALCIUM ACETATE 1 0.0002
6 SEVELAMER CARBONATE 2 0.0002
7 MICAFUNGIN SODIUM 1 0.0002
8 ALTEPLASE 2 0.0001
9 PYRAZINAMIDE 1 0.0001
See all drugs enriched for association with PSEUDOHYPERPHOSPHATAEMIA